Found 11 matching trials
Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer PHASE2 This study is a prospective, single-center, open-label, umbrella-shaped pha...
Show More Location
Cancer Hospital Affiliated to Fudan University
Learn More & Join Trial
Clinical Study of Camrelizumab Combined With APatinib and Albumin Paclitacxel in Patients With Advanced Lung Adenocarcinoma PHASE2 This study is a single arm, open label, national multicenter study, to expl...
Show More Location
Fujian Cancer Hospital
Learn More & Join Trial
FUSCC Refractory TNBC Umbrella (FUTURE) PHASE1 This is a Phase Ib/II, open-label, multi-center umbrella study evaluating t...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Becotatug Vedotin Combined With Pucotenlimab as Neoadjuvant Therapy for Resectable Recurrent Head and Neck Squamous Cell Carcinoma After Progression on Immunotherapy: A Prospective Phase II Study PHASE2 This is a prospective, single-arm, multi-center, Phase II clinical trial ev...
Show More Location
The First People's Hospital of Foshan
Learn More & Join Trial
A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors PHASE1 To assess safety and tolerability, describe the dose-limiting toxicities, a...
Show More Learn More & Join Trial
EGFR-ADC (Becotatug Vedotin) Combined With PD-1 Inhibitor (Pucotenlimab) in Neoadjuvant Treatment of Advanced Penile Cancer PHASE2 This clinical study is a Phase II research trial focused on a new preoperat...
Show More Location
West China Hospital of Sichuan University
Learn More & Join Trial
Study of DF9001 in Patients With Advanced Solid Tumors PHASE1 DF9001-001 is a study of a new molecule that targets natural killer (NK) ce...
Show More Location
Banner MD Anderson
Learn More & Join Trial
A Pan-RAS Inhibitor in Combination With Anti-Tumor Therapy in Participants With Advanced Pancreatic Cancer PHASE1 This study aims to evaluate the safety, tolerability, and efficacy of HRS-2...
Show More Location
the First Affiliated Hospital, School of Medicine
Learn More & Join Trial
PD-1 Inhibitor Plus Anti-EGFR Therapy And Radiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy PHASE2 Because nasopharyngeal carcinoma (NPC)is very sensitive to radiation and th...
Show More Location
Eye & ENT Hospital of Fudan University
Learn More & Join Trial
A Phase II Study of AK146D1 in Combination With AK112 in Advanced Non-Small Cell Lung Cancer PHASE2 This is a phase II clinical study evaluating the safety, tolerability, phar...
Show More Location
SunYat-sen University Cancer Center
Learn More & Join Trial